Skip to main content
. 2023 Aug 31;24(17):13537. doi: 10.3390/ijms241713537

Table 1.

List of selected manuscripts in alphabetical order.

Reference Title Sample/Model AhR Agonist AhR Antagonist Main Results
(Agbor et al., 2011)
[34]
Endothelial cell-specific aryl hydrocarbon receptor knockout mice exhibit hypotension mediated, in part, by an attenuated angiotensin II responsiveness Abdominal aorta from WT and ECAhR KO mouse --- ---
  • Decrease in ATR1 protein expression in abdominal aorta from ECAhR KO.

  • Hypotension in ECAhR KO unrelated to sympathetic or NO contribution.

  • Reduced downstream signalling of Ang II in ECAhR KO.

(Dou et al., 2015)
[35]
The cardiovascular effect of the uremic solute indole-3 acetic acid HUVECs IAA
5–50 μM
CH-223191 10 μM
  • Incubation with IAA increases COX-2 mRNA expression by AhR/p38MAPK/NFKB.

  • IAA causes oxidative stress partially mediated by AhR activation.

  • IAA is a predictor of cardiovascular mortality in patients with CKD.

(Fehsel et al., 2022)
[36]
Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction Aorta from AhR KO mouse Clozapine 1 μM CH-223191 10 μM
  • Decreased Emax in endothelial-dependent vasodilation in the presence of clozapine in WT but not in KO mouse.

  • AhR activity opposes to endothelium- dependent vasodilation.

(da Silva et al., 2022)
[37]
Aryl hydrocarbon receptor (AhR) activation contributes to high-fat diet-induced vascular dysfunction Thoracic aorta from AhR KO mouse fed an HFD

HUVECs
--- CH-223191 1 μM
  • Increase in AhR protein expression in thoracic aorta from WT mice fed an HFD.

  • HFD decreases endothelial-dependent vasodilation in thoracic aorta from WT mice but not from AhR KO mice.

  • Increase in NO production in thoracic aorta from AhR KO mice.

  • In HUVECs, AhR antagonist reverts the decreased levels of NO induced by LPC.

  • AhR KO protects against endothelial dysfunction induced by HFD.

(Gondouin et al., 2013)
[38]
Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway HUVECs IS 1 mM
IAA 50 μM
---
  • Increase in TF mRNA levels and eight genes regulated by AhR.

  • IS and IAA increase TF via AhR proning to atherogenesis in CKD patients.

(Ito et al., 2016)
[39]
Crucial Role of the Aryl Hydrocarbon Receptor (AhR) in Indoxyl Sulfate-Induced Vascular Inflammation HUVECs
ECAhR KO mouse
IS
0.2–2 mM
---
  • IS increases leukocyte–endothelial interactions through AP-1 transcriptional activity, and si AhR reverses it in HUVECs.

  • Decrease in inflammation and leukocyte recruitment in ECAhR KO.

(Kim et al., 2017)
[40]
Indoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD) HUVECs IS 1 mM ---
  • TNF-α produced by IS-conditioned monocytes from patients with CKD lead HUVECs to secrete CX3CL1 to further recruit immune cells, promote apoptosis and endothelial cell dysfunction.

(Koizumi et al., 2014)
[41]
Aryl hydrocarbon receptor mediates indoxyl sulfate-induced cellular senescence in human umbilical vein endothelial cells HUVECs IS 500 μM α-NF 10 μM
CH-223191 10 μM
  • IS activates NADPH oxidase.

  • IS decreases iNampt and Sirtuin 1 activity, which is reversed by AhR inhibition.

  • AhR blockade may be useful for the treatment of cardiovascular complications in patients with CKD.

(Lano et al., 2020)
[42]
Aryl Hydrocarbon Receptor Activation and Tissue Factor Induction by Fluid Shear Stress and Indoxyl Sulfate in Endothelial Cells HUVECs IS 200 μM
Shear Stress
Genistein
  • IS and shear stress increase COX-2 and TF mRNA expression.

  • IS induces TF activation with procoagulant effect.

  • SS induces TF activation without procoagulant effect.

  • IS and SS activate AhR by different mechanisms.

(Li et al., 2017)
[43]
ITE Suppresses Angiogenic Responses in Human Artery and Vein Endothelial Cells: Differential Roles of AhR HUVECs
HUAECs
ITE 1 μM ---
  • ITE decreases the proliferation and viability of HUAECs in an AhR-independent manner and HUVECs in an AhR-dependent manner.

  • ITE decreases AhR protein levels in HUAECs and HUVECs.

  • ∙ ITE increases CYP1A1 and CYP1B1 mRNA levels in HUAECs and HUVECs.

(Long et al., 2021)
[44]
3′-Oxo-tabernaelegantine A (OTNA) selectively relaxes pulmonary arteries by inhibiting AhR Pulmonary artery and thoracic aorta from C57BL/6 mouseHUVECs & HPAECs ITE 20 μM OTNA
CH-223191 10 μM
  • OTNA inhibits AhR and induces vasodilation in pulmonary artery by activating the PI3K/Akt/eNOS pathway.

  • ITE blocks the vasodilation of OTNA, and CH-223191 produces a synergistic effect with OTNA.

  • AhR inhibition could treat pulmonary arterial hypertension.

(Lund et al., 2008)
[45]
Loss of the aryl hydrocarbon receptor induces hypoxemia, endothelin-1, and systemic hypertension at modest altitude Plasma from
AhR KO mouse
HUVECs and microvascular ECs from lung
--- ---
  • AhR KO at low altitude induces hypotension.

  • AhR KO at modest altitude induces hypertension.

  • Increase in ET-1 plasma levels in AhR KO does not originate in pulmonary vessels.

  • Decreased in PreproET-1 mRNA levels in AhR-specific siRNA HUVECs and microvascular ECs from lung.

(Masaki et al., 2021)
[46]
Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension ECs from SU5416/hypoxia
AhR KO rat lung
FICZ
10 mg/kg/wk
subcutaneous administration
---
  • ECs from lung of SU5416/hypoxia rat model have an increase in AhR expression.

  • FICZ, in combination with hypoxia, induces severe PAH.

  • AhR activity is directly proportional to the severity of pathogenesis of PAH.

(Nakagawa et al., 2021)
[47]
Indoxyl sulfate induces ROS production via the aryl hydrocarbon receptor-NADPH oxidase pathway and inactivates NO in vascular tissues. Thoracic aorta from rat IS 250–1000 μM CH-223191 10 μM
  • Increase in O2●− production by IS through activation of NADPH oxidase.

  • Decreased endothelium-dependent vasodilation in the presence of IS that was partially reversed by AhR antagonist.

(Nakagawa et al., 2022)
[48]
Acute Kynurenine Exposure of Rat Thoracic Aorta Induces Vascular Dysfunction via Superoxide Anion Production Thoracic aorta from rat Kynurenine
10–500 µM
CH-223191 10 μM
  • Kynurenine increases O2●− production, leading to decreased endothelium-dependent vasodilation.

(Nguyen et al., 2022)
[49]
Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings. Aorta from rat IS
10–300 μM
CH-223191 10 μM
  • Increase in O2●− production by IS through activation of NADPH oxidase.

  • Decreased endothelium-dependent vasodilation only at IS 300 μM.

(Wang et al., 2016)
[50]
Suppression of Lipid Accumulation by Indole-3-Carbinol Is Associated with Increased Expression of the Aryl Hydrocarbon Receptor and CYP1B1 Proteins in Adipocytes and with Decreased Adipocyte-Stimulated Endothelial Tube Formation Murine preadipocyte cell line 3T3-L1
Human endothelium-derived cell line EA hy926
I3C 50 μM ---
  • Decrease in pro-angiogenic mediators in adipocytes incubated with I3C.

  • Decrease in endothelial angiogenesis when ECs are incubated with I3C adipocyte conditioned medium.

(Zhang et al., 2022)
[51]
Kynurenine promotes neonatal heart regeneration by stimulating cardiomyocyte proliferation and cardiac angiogenesis CMECs
from mouse
AhR KO mouse
Kynurenine from cardiomyocytes ---
  • Kynurenina transport between cardiomyocytes and EC.

  • ∙ Increase in VEGFA gene expression by AhR activation in EC.

  • Decrease in VEGFA in cardiac endothelium from AhR KO.

(Zhang et al., 2010)
[52]
An activated renin–angiotensin system maintains normal blood pressure in aryl hydrocarbon receptor heterozygous mice but not in null mice Thoracic aorta from AhR+/+, AhR+/− and AhR−/− mouse --- ---
  • Increase in eNOS protein expression in AhR−/−mouse.

  • ∙ Further decrease in mean arterial pressure in AhR−/− than AhR+/− mouse.

  • Further increase in response to ACE inhibitor or ETA antagonist of AhR+/− than AhR−/− mouse.

WT: wild type; ECAhR: Endothelial cell-specific AhR knockout; ATR1: Angiotensin II receptor type 1; NO: Nitric oxide; Ang II: Angiotensin II; HUVECs: Human Umbilical Vein Endothelial Cells; -; Emax: maximal effect; CKD: Chronic kidney disease; HFD: High-fat diet; LPC: Lysophosphatidylcholine; ECs: Endothelial cells; IAA: Indole-3-acetic acid; TF: tissue factor, IS: Indoxyl sulfate, α-NF: α-naphthoflavone; (iNampt): intracellular nicotinamide phosphoribosyltransferase; HUAECs: Human artery endothelial cells; HPAECs: Human pulmonary artery endothelial cells; CMECs: Cardiac microvascular endothelial cells; ITE: 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester; FICZ: formylindolo[3,2-b]carbazole; I3C: Indole-3-carbinol.